Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$569K Sell
10,307
-1,923
-16% -$104K 0.34% 63
2025
Q4
$600K Buy
12,230
+202
+2% +$9.42K 0.39% 56
2025
Q3
$531K Buy
+12,028
New +$470K 0.35% 64

Other funds holding GSK

Code Waechter's GSK Position: Q1 2026 in Review

Code Waechter reduced its GSK (GSK) stake by 16% in Q1 2026, selling an estimated $104K and leaving 10,307 shares worth $569K. The position accounts for 0.34% of the portfolio, ranked #63.

Code Waechter first reported a position in GSK in Q3 2025 and has held it in 3 quarters since. The position peaked at $600K in Q4 2025. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Code Waechter held 10,307 shares of GSK worth $569K as of Q1 2026.
  • Code Waechter sold 1,923 GSK shares in Q1 2026, an estimated $104K.
  • GSK made up 0.34% of Code Waechter's portfolio in Q1 2026, its #63 holding.
  • Code Waechter first reported a position in GSK in Q3 2025 and has held it in 3 quarters since.
  • Code Waechter's GSK position peaked at $600K in Q4 2025.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Code Waechter's 13F filing for Q1 2026, filed 15 Apr 2026.